Design Therapeutics Stock Forecast - Accumulation Distribution
| DSGN Stock | USD 5.57 0.09 1.64% |
Design Stock Forecast is based on your current time horizon. Although Design Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Design Therapeutics' systematic risk associated with finding meaningful patterns of Design Therapeutics fundamentals over time.
Design |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 2990.22 | 4354.49 |
| Check Design Therapeutics Volatility | Backtest Design Therapeutics | Trend Details |
Design Therapeutics Trading Date Momentum
| On October 25 2024 Design Therapeutics was traded for 5.44 at the closing time. The top price for the day was 5.49 and the lowest listed price was 5.31 . The trading volume for the day was 66.3 K. The trading history from October 25, 2024 was a factor to the next trading day price boost. The overall trading delta against the next closing price was 1.68% . The overall trading delta against the current closing price is 2.80% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Design Therapeutics to competition |
Other Forecasting Options for Design Therapeutics
For every potential investor in Design, whether a beginner or expert, Design Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Design Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Design. Basic forecasting techniques help filter out the noise by identifying Design Therapeutics' price trends.Design Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Design Therapeutics stock to make a market-neutral strategy. Peer analysis of Design Therapeutics could also be used in its relative valuation, which is a method of valuing Design Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Design Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Design Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Design Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Design Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Design Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Design Therapeutics shares will generate the highest return on investment. By undertsting and applying Design Therapeutics stock market strength indicators, traders can identify Design Therapeutics entry and exit signals to maximize returns.
Design Therapeutics Risk Indicators
The analysis of Design Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Design Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting design stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.28 | |||
| Semi Deviation | 5.42 | |||
| Standard Deviation | 5.81 | |||
| Variance | 33.78 | |||
| Downside Variance | 34.95 | |||
| Semi Variance | 29.42 | |||
| Expected Short fall | (4.66) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Design Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Design Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Design Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Design Stock
| 0.52 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.5 | KALV | Kalvista Pharmaceuticals | PairCorr |
| 0.49 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.49 | KTTA | Pasithea Therapeutics | PairCorr |
| 0.47 | INZY | Inozyme Pharma | PairCorr |
The ability to find closely correlated positions to Design Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Design Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Design Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Design Therapeutics to buy it.
The correlation of Design Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Design Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Design Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Design Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of Design Therapeutics to cross-verify your projections. To learn how to invest in Design Stock, please use our How to Invest in Design Therapeutics guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Design Therapeutics. If investors know Design will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Design Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.85) | Revenue Per Share 0.001 | Return On Assets (0.14) | Return On Equity (0.18) |
The market value of Design Therapeutics is measured differently than its book value, which is the value of Design that is recorded on the company's balance sheet. Investors also form their own opinion of Design Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Design Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Design Therapeutics' market value can be influenced by many factors that don't directly affect Design Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Design Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Design Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Design Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.